Inflammatory Potential of the Diet and Incidence of Crohn's Disease and Ulcerative Colitis in the EPIC-Spain Cohort.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
26 Jun 2021
Historique:
received: 12 05 2021
revised: 22 06 2021
accepted: 24 06 2021
entrez: 2 7 2021
pubmed: 3 7 2021
medline: 17 8 2021
Statut: epublish

Résumé

Diet may influence the development of inflammatory bowel disease through the modulation of inflammation. We investigated whether the inflammatory potential of the diet is associated with the risk of Crohn's disease (CD) and ulcerative colitis (UC) in the Spanish cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Spain). The study included 32,633 participants aged 29-69 years. The inflammatory potential of the diet was measured by using an inflammatory score of the diet (ISD) based on a baseline dietary history questionnaire. Cox regression was used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs). During 21 years (674,547 person-years) of follow-up, 32 and 57 participants developed CD and UC, respectively. In multivariable analysis, a one-standard deviation (SD) increment in the ISD (two-unit increase) was associated with a higher risk of CD (HR of 1.71; 95% CI: 1.05-2.80;

Identifiants

pubmed: 34206846
pii: nu13072201
doi: 10.3390/nu13072201
pmc: PMC8308349
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Instituto de Salud Carlos III
ID : PIE14/00045
Organisme : Crohn's and Colitis UK
ID : M2017-2
Organisme : Intra-CIBERESP mobility program
ID : ESPF60/2017
Organisme : International Agency for Research on Cancer
ID : AEP/93/06

Références

Am J Gastroenterol. 2010 Oct;105(10):2195-201
pubmed: 20461067
J Intern Med. 2017 Jan;281(1):75-85
pubmed: 27485145
Nutrients. 2018 Jan 10;10(1):
pubmed: 29320413
Gut. 2014 May;63(5):776-84
pubmed: 23828881
Perm J. 2019;23:18-107
pubmed: 30624192
Lancet. 2018 Dec 23;390(10114):2769-2778
pubmed: 29050646
Int J Cardiol. 2017 Aug 1;240:409-413
pubmed: 28487151
Nutrients. 2018 Aug 08;10(8):
pubmed: 30096775
Br J Nutr. 2015 Feb 28;113(4):665-71
pubmed: 25639781
Nutr Res. 2015 Sep;35(9):753-8
pubmed: 26126709
Mol Nutr Food Res. 2017 Aug;61(8):
pubmed: 28130829
Am J Clin Nutr. 2016 Mar;103(3):878-85
pubmed: 26864363
Semin Immunopathol. 2018 Feb;40(2):145-156
pubmed: 29124320
Atherosclerosis. 2015 Jan;238(1):38-44
pubmed: 25437888
Nutr J. 2019 Nov 4;18(1):65
pubmed: 31684946
Nutr Rev. 2013 Aug;71(8):511-27
pubmed: 23865797
Inflamm Bowel Dis. 2016 Feb;22(2):345-54
pubmed: 26717318
Eur J Epidemiol. 2012 Jan;27(1):15-25
pubmed: 22089423
Front Immunol. 2017 Aug 14;8:942
pubmed: 28855901
Int J Cancer. 2017 Dec 1;141(11):2215-2227
pubmed: 28795402
Lancet. 2007 May 12;369(9573):1641-57
pubmed: 17499606
Eur J Clin Nutr. 2007 Sep;61(9):1037-56
pubmed: 17375121
Nutr Rev. 2021 Feb 11;79(3):331-350
pubmed: 32417914
Nutrients. 2020 Mar 29;12(4):
pubmed: 32235316
Nutr Cancer. 2016;68(3):404-9
pubmed: 27030369
Inflamm Bowel Dis. 2008 Mar;14(3):367-73
pubmed: 18092347
Int J Cancer. 2020 Aug 15;147(4):1027-1039
pubmed: 31945199
Front Nutr. 2021 Feb 10;7:602090
pubmed: 33681269
Nutrients. 2017 Sep 20;9(9):
pubmed: 28930191
Gastroenterology. 2014 Apr;146(4):929-31
pubmed: 24406470
Am J Clin Nutr. 2004 Oct;80(4):1029-35
pubmed: 15447916
Public Health Nutr. 2002 Dec;5(6B):1113-24
pubmed: 12639222
Eur Heart J. 2004 Dec;25(23):2092-100
pubmed: 15571824
Gastroenterology. 2020 Sep;159(3):873-883.e1
pubmed: 32389666
Eur J Gastroenterol Hepatol. 2015 Jun;27(6):623-30
pubmed: 25831134
Cell. 2016 Nov 17;167(5):1339-1353.e21
pubmed: 27863247
Br J Clin Pharmacol. 2017 Jan;83(1):107-113
pubmed: 26935858
Gut. 2009 Dec;58(12):1606-11
pubmed: 19628674
Inflamm Bowel Dis. 2021 Jan 19;27(2):190-202
pubmed: 32206803
Int J Epidemiol. 1997;26 Suppl 1:S100-9
pubmed: 9126538
Nat Rev Gastroenterol Hepatol. 2018 Sep;15(9):525-535
pubmed: 29789682
Public Health Nutr. 2014 Aug;17(8):1689-96
pubmed: 23941862
Rev Esp Salud Publica. 2004 Mar-Apr;78(2):167-76
pubmed: 15199795
Am J Clin Nutr. 2018 Apr 1;107(4):607-616
pubmed: 29635497
Eur J Nutr. 2020 Mar;59(2):813-823
pubmed: 30903361
Clinicoecon Outcomes Res. 2019 Mar 12;11:221-232
pubmed: 30881067
Gut. 2020 Sep;69(9):1637-1644
pubmed: 31900290
J Dig Dis. 2020 Jul;21(7):362-371
pubmed: 32463159
J Crohns Colitis. 2013 May;7(4):322-37
pubmed: 23395397

Auteurs

Marcela Guevara (M)

Instituto de Salud Pública de Navarra, 31003 Pamplona, Spain.
Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), 28029 Madrid, Spain.
Navarra Institute for Health Research (IdiSNA), 31008 Pamplona, Spain.

Elena Salamanca-Fernández (E)

Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), 18012 Granada, Spain.

Estrella Miqueleiz (E)

Instituto de Salud Pública de Navarra, 31003 Pamplona, Spain.

Diana Gavrila (D)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), 28029 Madrid, Spain.
Department of Epidemiology, Murcia Regional Health Council, IMIB-Arrixaca, 30008 Murcia, Spain.

Pilar Amiano (P)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), 28029 Madrid, Spain.
Sub-Directorate for Public Health and Addictions of Gipuzkoa, Ministry of Health of the Basque Government, 20013 San Sebastian, Spain.
Epidemiology and Public Health Area, Biodonostia Health Research Institute, 20014 San Sebastian, Spain.

Catalina Bonet (C)

Unit of Nutrition and Cancer, Catalan Institute of Oncology-ICO, and Nutrition and Cancer Group, Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, Bellvitge Biomedical Research Institute-IDIBELL, 08908 L'Hospitalet de Llobregat, Spain.

Miguel Rodríguez-Barranco (M)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), 28029 Madrid, Spain.
Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), 18012 Granada, Spain.
Andalusian School of Public Health (EASP), 18011 Granada, Spain.

José María Huerta (JM)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), 28029 Madrid, Spain.
Department of Epidemiology, Murcia Regional Health Council, IMIB-Arrixaca, 30008 Murcia, Spain.

Luis Bujanda (L)

Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, 20014 San Sebastian, Spain.
Department of Gastroenterology, University of the Basque Country (UPV/EHU), 20018 San Sebastian, Spain.
Consortium for Biomedical Research in Hepatic and Digestive Diseases, CIBEREHD, 28029 Madrid, Spain.

María José Sánchez (MJ)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), 28029 Madrid, Spain.
Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), 18012 Granada, Spain.
Andalusian School of Public Health (EASP), 18011 Granada, Spain.
Department of Preventive Medicine and Public Health, University of Granada, 18071 Granada, Spain.

María Dolores Chirlaque (MD)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), 28029 Madrid, Spain.
Department of Epidemiology, Murcia Regional Health Council, IMIB-Arrixaca, 30008 Murcia, Spain.
Departamento de Ciencias Sociosanitarias, Facultad de Medicina, Universidad de Murcia, 30100 Murcia, Spain.

Antonio Agudo (A)

Unit of Nutrition and Cancer, Catalan Institute of Oncology-ICO, and Nutrition and Cancer Group, Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, Bellvitge Biomedical Research Institute-IDIBELL, 08908 L'Hospitalet de Llobregat, Spain.

Eva Ardanaz (E)

Instituto de Salud Pública de Navarra, 31003 Pamplona, Spain.
Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), 28029 Madrid, Spain.
Navarra Institute for Health Research (IdiSNA), 31008 Pamplona, Spain.

Jesús Castilla (J)

Instituto de Salud Pública de Navarra, 31003 Pamplona, Spain.
Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), 28029 Madrid, Spain.
Navarra Institute for Health Research (IdiSNA), 31008 Pamplona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH